Who Should Pay to Clean Up 'Forever Chemicals'? Not us, representatives of water utilities and landfills say at a Senate hearing Mar 20, 2024
Mutation Linked to Increased Risk of Prostate Cancer Mortality Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
Lenvatinib-Pembrolizumab Combo Misses on Survival in Endometrial Cancer Trial Combination in first-line fails to improve progression-free, overall survival versus chemotherapy Mar 20, 2024
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin Dose-dependent increase regardless of age at treatment or chest radiotherapy Mar 19, 2024
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer Use of the PARP inhibitor improved PFS by 19.4 months versus placebo in phase II study Mar 19, 2024
EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban New rule would prohibit chrysotile asbestos Mar 19, 2024
Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence Growing body of data suggest it can be safe and effective in low-risk disease, says expert Mar 18, 2024
Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesions Response rate doubles with the noninvasive treatment versus placebo Mar 18, 2024
How Often Should Immunocompromised People Get a COVID Booster? Experts say about every 6 months, but that should be individualized Mar 18, 2024
Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says Mar 18, 2024
Laparoscopy Quickly Abandoned in Early Cervical Cancer After LACC Results MIS roughly halved in the 2 years following the study results, national dataset shows Mar 18, 2024
Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer Dostarlimab and pembrolizumab regimens should be incorporated into practice "as of yesterday" Mar 17, 2024
Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer Novel ADC targeting CDH6 achieves response in nearly 50% of patients Mar 17, 2024
FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
Delta-8 THC Use Common in Teens; New Drug-Coated Balloon for Blocked Stents Also in TTHealthWatch: new screening methods for colorectal cancer Mar 16, 2024 podcast
EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
FDA Approves First CAR-T for Chronic Lymphocytic Leukemia Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
New PD-1 Inhibitor Approved for Esophageal Cancer Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
FDA Panel Endorses Imetelstat for MDS-Related Anemia By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
Rheumatologist Found Dead; How COVID Changed Lives; Olivia Munn's Breast Cancer Health news and commentary from around the Web gathered by 名媛直播 staff Mar 14, 2024
Olivia Munn Reveals Breast Cancer Diagnosis and Double Mastectomy A high Breast Cancer Risk Assessment Score led to imaging and a biopsy Mar 14, 2024
Novel CAR-T for Glioblastoma Induced 'Dramatic' Responses in Early Trial In three patients, one-time infusion of CARv3-TEAM-E T cells resulted in rapid tumor regression Mar 13, 2024
Noninvasive Screening Tests Show Promise for Catching Colorectal Cancer Could these tests help to increase the number of people who undergo screening? Mar 13, 2024
FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recs Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain Mar 11, 2024
Banning Gain-of-Function Research Would Do Far More Harm Than Good A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
Knowing When to Start, Knowing When to Stop Discussions about screening recommendations can be difficult, but they're worth having Mar 11, 2024
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
FDA OKs First Interchangeable Biosimilars for Denosumab New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pond Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubt "Every month that you're not pregnant feels like grief" Mar 05, 2024
All-Oral AML Regimen Shows Promise for Older, Unfit Patients Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
More Evidence Linking H. Pylori Infection to Colorectal Cancer Increased CRC incidence and mortality, significantly reduced by infection treatment Mar 05, 2024
Novel Therapy Promising for Radiation-Induced Oral Mucositis No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024
